The aim of this study is to evaluate the peripheral muscle function, sleep disorders and physical activity level in children with cystic fibrosis who are physically inactive at home due to social isolation and to examine the effect of the 6-week online exercise protocol.
Considering the new coronavirus (COVID-19) pandemic global information, some patient
populations have been identified at higher risk of this pandemic like older age,
hypertension, cardiovascular and respiratory diseases. Self- isolation is recommended for
preventive strategy in cystic fibrosis patients. Long-term social isolation and school
closure can have negative effects on childrens' physical and mental health. Due to social
isolation childrens are less physical active, have longer screen exposure and irregular sleep
patterns.
There is no study to evaluate the the peripheral muscle function, sleep disorders and
physical activity level and examine the effects of exercise training in children with cystic
fibrosis in social isolation due the COVID-19 pandemic.
This study will be included children with cystic fibrosis who had stabile conditions
Patients' peripheral muscle function, sleep quality and physical activity level will be
assess and record at beginning, after the twelve and eighteen session.
Other: Telerehabilitation-based
15 pediatric cystic fibrosis patients who are at home during the self- isolation process due to the COVID-19 pandemic will be included in this group. Online exercise training protocol will be apply for patients. Each training protocol was planned as 30 minutes for 3 days a week for 6 weeks with a physiotherapist. Exercise protocol will start with the warm-up exercises and finish with cooling exercises.
Other: Follow-up based
15 pediatric cystic fibrosis patients who are at home during the self- isolation process due to the COVID-19 pandemic will be included in this group. An exercise document including the same exercise protocol in study group will be sent the patients. Patients will be called by the physiotherapist once a week for follow-up. .
Inclusion Criteria:
- People who diagnosed cystic fibrosis disease at stabile conditions.
- Volunteering to participate in the study,
- Having a social isolation due to COVID-19 pandemic
- Having forced expiratory volume at one second (FEV1) %> 40 % at last pulmonary
function test.
Exclusion Criteria:
- Being diagnosed with acute pulmonary exacerbation at the time of study and / or within
the last month.
- having a diagnosed with COVID-19 before or during the study
- Being physically or perceptually competent to exercise
- Patients with allergic bronchopulmonary aspergillosis (ABPA) who were treated with
systemic steroid therapy
- Patients who were not complete the exercise training ability.
- Having FEV1 %< 40% at pulmonary function test.
Hacettepe University
Ankara, Turkey
Investigator: Kubra Kilic, MsC
Contact: +903123051576
fztktas@gmail.com
Kubra Kilic, PhD Student
+903123051576
fztktas@gmail.com
Hacettepe University
+903123051576
Deniz Dogru-Ersoz, Professor, Principal Investigator
Hacettepe University